Allogene Therapeutics (ALLO) Net Cash Flow (2018 - 2026)
Allogene Therapeutics' Net Cash Flow was $8.32 million in Q2 2026, down 15.8% from $9.88 million a year earlier.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Net Cash Flow (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Allogene Therapeutics' Net Cash Flow was -$13.71 million through Jun 30, 2026; for FY2025, it came in at -$23.53 million.
- In earlier years, Net Cash Flow was -$7.94 million in FY2024, $21.25 million in FY2023, -$111.41 million in FY2022 and -$9.19 million in FY2021.
- Quarterly Net Cash Flow has moved between -$119.43 million (Q3 2024) and $119.63 million (Q2 2024) over five years.
- Compared with a year earlier, Net Cash Flow was higher in 1 of the last four quarters, with an average decline of 19.3%.
- Per Business Quant data, ALLO's Net Cash Flow in the three quarters before Q2 2026 was -$21.38 million (Q1 2026), $13.87 million (Q4 2025) and -$14.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.72 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -3.52 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.53 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | -3.94 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -4.43 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -722.00 Mn |
| 10 | Allogene Therapeutics | 401.29 Mn | -700.60 Mn | - | 8.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.32 Mn |
| Mar 31, 2026 | -21.38 Mn |
| Dec 31, 2025 | 13.87 Mn |
| Sep 30, 2025 | -14.52 Mn |
| Jun 30, 2025 | 9.88 Mn |
| Mar 31, 2025 | -32.76 Mn |
| Dec 31, 2024 | 23.98 Mn |
| Sep 30, 2024 | -119.43 Mn |
| Jun 30, 2024 | 119.63 Mn |
| Mar 31, 2024 | -32.12 Mn |
| Dec 31, 2023 | 13.91 Mn |
| Sep 30, 2023 | -85.51 Mn |
| Jun 30, 2023 | 44.83 Mn |
| Mar 31, 2023 | 48.03 Mn |
| Dec 31, 2022 | -12.45 Mn |
| Sep 30, 2022 | -21.68 Mn |
| Jun 30, 2022 | 11.53 Mn |
| Mar 31, 2022 | -88.80 Mn |
| Dec 31, 2021 | -15.86 Mn |
| Sep 30, 2021 | -33.48 Mn |
API Access
Allogene Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();